Pitcairn’s BioNTech BNTX Stock Holding History

Pitcairn’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,198	Closed	-$337K	–	718
2024 Q2	$337K	Buy	4,198 +923	+28%	+$84.4K	0.02%	551
2024 Q1	$302K	Sell	3,275 -2,725	-45%	-$261K	0.02%	578
2023 Q4	$633K	Buy	+6,000	New	+$605K	0.05%	331

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pitcairn's BNTX Position: Q3 2024 in Review

Pitcairn sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 4,198 shares — an estimated $337K sold.

Pitcairn first reported a position in BNTX in Q4 2023 and held it in 3 quarters. The position peaked at $633K in Q4 2023. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

Pitcairn reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
Pitcairn sold 4,198 BioNTech shares in Q3 2024, an estimated $337K.
Pitcairn first reported a position in BioNTech in Q4 2023 and held it in 3 quarters.
Pitcairn's BioNTech position peaked at $633K in Q4 2023.
296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Pitcairn's 13F filing for Q3 2024, filed 12 Nov 2024.